Encore Enterprises Doubles-Down on Dallas: Acquires Class B Commercial Medical Office Building, Reopens Corporate HQ as Owner-Occupied Tenant
Despite tough lending climate, banks’ continued struggle with commercial office portfolios, Encore secures loan on $7 million property through Cadence Bank in... Read more.
BostonGene’s Multiomic AI Platform Uncovers Therapeutic Targets in Invasive Lobular Carcinoma, Wins GRASP Advocate Choice Award at ASCO 2025
Study Identifies Disease-Specific Targets to Inform Precision Drug Development in Breast Cancer WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leader in... Read more.
Co-operators Transforms Claims Operations with Guidewire ClaimCenter on Guidewire Cloud Platform
Subsidiary Sovereign Insurance also leveraging ClaimCenter for claims management GUELPH, Ontario & SAN MATEO, Calif.–(BUSINESS WIRE)–$GWRE #GuidewireBillingCenter—Co-operators,... Read more.
Europe Edge Data Center Market Analysis and Forecast, 2025-2034: Energy Demand and Regulatory Complexities Constrain EU Data Center Deployment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Edge Data Center Market: Focus on Product, Application, and Country Analysis – Analysis and Forecast,... Read more.
Hungary Employee Benefits Report 2025: Supplementary Pension, Healthcare Benefits, Unemployment Benefits, Disability Benefits, and Death Benefits – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Employee Benefits in Hungary 2025” report has been added to ResearchAndMarkets.com’s offering. The report... Read more.
Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy
BOSTON–(BUSINESS WIRE)–Anodyne Nanotech, a clinical-stage biotech company, today announced new preclinical data demonstrating that administration of... Read more.
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders
PYRUKYND® (mitapivat) is a first-in-class pyruvate kinase (PK) activator, approved by the European Commission for adults with PK deficiency The agreement includes... Read more.
Citigroup Enterprise Tech Ecosystem Company Profile 2025: Digital Transformation Strategies and Innovation Programs – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Enterprise Tech Ecosystem Series – Citigroup Inc. 2025” company profile has been added to ResearchAndMarkets.com’s... Read more.
Airport Lounge Access Market Report 2025: Analysis by Ownership, Access Method, Travel Type, Region and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Airport Lounge Access Market (2025 Edition): Analysis By Ownership (Airline, Airport, Government Owned, and Privately... Read more.
Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder
Results demonstrated that nicotinamide riboside (NR) significantly elevated NAD+ levels and improved multiple clinical markers in people with Werner Syndrome Niagen... Read more.